Deutsche Bank’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
MAP
PAP
SO
Deutsche Bank's BIOA Position: Q2 2026 in Review
Deutsche Bank increased its BioAge Labs (BIOA) stake by 49% in Q2 2026, buying an estimated $202K and bringing the position to 34,298 shares worth $841K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.
Deutsche Bank first reported a position in BIOA in Q1 2025 and has held it in 6 quarters since. 37 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.
- Deutsche Bank held 34,298 shares of BioAge Labs worth $841K as of Q2 2026.
- Deutsche Bank bought 11,202 BioAge Labs shares in Q2 2026, an estimated $202K.
- BioAge Labs made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2475 holding.
- Deutsche Bank first reported a position in BioAge Labs in Q1 2025 and has held it in 6 quarters since.
- 37 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.